GOTHAM THERAPEUTICS
Gotham Therapeutics is discovering a novel drug class targeting the epitranscriptomics machinery.The company offers treatment options for patients suffering from cancers, auto-immune and neurodegenerative diseases.
GOTHAM THERAPEUTICS
Industry:
Biotechnology Life Science Therapeutics
Founded:
2017-01-01
Address:
New York, New York, United States
Country:
United States
Website Url:
http://www.gothamtx.com
Total Employee:
1+
Status:
Active
Email Addresses:
[email protected]
Total Funding:
54 M USD
Technology used in webpage:
Viewport Meta SPF SSL By Default Google Analytics LetsEncrypt Google Tag Manager Content Delivery Network Google Universal Analytics Global Site Tag Euro
Similar Organizations
Bicara Therapeutics
Bicara Therapeutics develops dual-action cancer therapies, combining targeted treatments with tumor modulators for enhanced impact.
Enliven Therapeutics
Enliven Therapeutics is a precision oncology company developing small molecule therapies to extend and improve patient lives.
Eureka Therapeutics
Eureka Therapeutics is a biotechnology company focusing on immunotherapies for the treatment of cancer.
Parthenon Therapeutics
Parthenon Therapeutics is a biotech company inventing a novel class of anti-cancer therapies that reprogram the tumor microenvironment.
Scholar Rock
Scholar Rock is a biopharmaceutical company that develops and discovers new medicines and treatments for the serious diseases.
Spero Therapeutics
Spero Therapeutics develops therapeutics for treatment of gram-negative infections.
Werewolf Therapeutics
Werewolf Therapeutics operates as an oncology biotherapeutics company.
Current Employees Featured
Founder
Investors List
Versant Ventures
Versant Ventures investment in Series A - Gotham Therapeutics
Forbion Capital Partners
Forbion Capital Partners investment in Series A - Gotham Therapeutics
SR One
SR One investment in Series A - Gotham Therapeutics
Official Site Inspections
http://www.gothamtx.com
- Host name: 137.184.251.94
- IP address: 137.184.251.94
- Location: New York United States
- Latitude: 40.7157
- Longitude: -74
- Metro Code: 501
- Timezone: America/New_York
- Postal: 10013
More informations about "Gotham Therapeutics"
Gotham Therapeutics - Crunchbase Company Profile & Funding
Contact Email [email protected] Gotham Therapeutics is discovering a novel drug class targeting the epitranscriptomics machinery.The company offers treatment options for patients …See details»
Gotham Therapeutics - LeadIQ
Oct 10, 2018 Versant Ventures invests into Gothamtx $54M. Gotham launched in 2018 with a $54 million Series A financing round, which was also co-led by Versant Ventures. Sep 20, …See details»
Gothamtx.com
Dec 16, 2024 Gothamtx.com adalah situs terbaik menyajikan berbagai informasi yang terbaru. Skip to content. Gothamtx.com. Menu. Kebijakan Privasi; Kontak; Tentang Gothamtx.com; Slot Posted on: 15 Februari 2025 15 Februari 2025. …See details»
Gotham Therapeutics - LinkedIn
Gotham Therapeutics has assembled an exceptional team and network to establish a novel drug class targeting RNA-modifying proteins. By changing the activity of proteins that modify messenger RNA ...See details»
Gotham Therapeutics - Company Profile - Tracxn
Jan 30, 2025 Email ID: *****@gothamtx.com; Key Metrics. Total Funding. $54M in 1 round. Latest Funding Round. Series A, Oct 01, 2018, $54M. Investors. Versant Ventures & 4 more. …See details»
Gotham Therapeutics - Overview, News & Similar companies
Feb 13, 2019 View Gotham Therapeutics (www.gothamtx.com) location in New York, United States , revenue, industry and description. Find related and similar companies as well as …See details»
Gotham Therapeutics Corp. - Drug pipelines, Patents, Clinical
Www.gothamtx.com. Last update 08 Mar 2025. Overview. Pipeline. Deal. Translational Medicine. Profit. Grant & Funding(NIH) Investment. Financing. ... The statistics for drugs in the Pipeline …See details»
Gotham Therapeutics - VentureRadar
Website: https://www.gothamtx.com/ Develops novel drug class targeting RNA-modifying proteins to create treatment options for cancer, auto-immune, and ...See details»
gothamtx.com Reviews | check if site is scam or legit| Scamadviser
Check gothamtx.com with our free review tool and find out if gothamtx.com is legit and reliable. Need advice? Report scams Check Scamadviser! Report a Scam Help & Info API & Data …See details»
Tentang Gothamtx.com - Gothamtx.com
Gothamtx.com merupakan domain yang telah kami akuisisi. Sebelumnya situs dengan domain gothamtx.com membagikan informasi ataupun jasa seputar Therapeutics yang bernama …See details»
Gotham Therapeutics - Craft
Gotham Therapeutics operates as a biotechnology company, which develops a novel drug class targeting epitranscriptomics machinery. It develops new treatments for patients suffering from …See details»
Gotham Therapeutics (USA) Funding: $54M - medicalstartups.org
Jan 22, 2025 Gotham Therapeutics is discovering a novel drug class targeting the epitranscriptomics...See details»
Gotham Therapeutics and Mercachem Announce Progress in
Jul 17, 2019 For more information, please visit: www.gothamtx.com About Mercachem and MercachemSyncom: Mercachem is part of MercachemSyncom, the leading European contract …See details»
Gotham Therapeutics and Mercachem Announce Progress in …
Jul 17, 2019 Gotham Therapeutics: Dr. Birgit Zech Chief Operating Officer +49 179 5340884 [email protected] Media Contact: Mario Brkulj and Amanda Houlihan MacDougall +49 …See details»
Real Estate Developer, Owner, and Manager | Gotham Organization
Gotham Organization is a vertically integrated developer, owner, and manager of real estate property in NYC and the East Coast, including over 4,200 luxury rentals. Home; About. Who …See details»
Gotham Therapeutics and ZoBio Achieve Significant Milestone in ...
May 21, 2019 proteins, and ZoBio, the leading contract research organization in integrated fragment-based drug discovery, today announced significant progress made as part of their …See details»
Gotham Therapeutics and ZoBio Achieve Significant Milestone in ...
May 21, 2019 Gotham Therapeutics: Dr. Birgit Zech Chief Operating Officer +49 179 5340884 [email protected] Media Contact: Mario Brkulj and Amanda Houlihan MacDougall +49 …See details»
Gotham Therapeutics Establishes Advanced Oncology Profiling …
[email protected] Media Contact: Mario Brkulj and Amanda Houlihan MacDougall +49 175 5711562 or +1 781-235-3060 [email protected] ProQinase: Dr. Sebastian Dempe …See details»
Gotham Therapeutics - Wiki - Golden
A biotechnology company discovering drugs that target the epitranscriptomics machinery that modifies RNA.See details»
Gotham Therapeutics and ZoBio Achieve Significant Milestone in ...
May 21, 2019 NEW YORK, NY, USA & LEIDEN, The Netherlands I May 21, 2019 I Gotham Therapeutics, a biotechnology company developing a novel drug class targeting RNA …See details»